Attention Deficit Disorder Research headlines for
Friday, 29 August 2008 04:46 am
Hayes Evaluates Test And Treatment Options For Attention-Deficit Hyperactivit...
24 Aug 2008 at 7:13am
Hayes, Inc., an industry leader in providing independent, unbiased analyses of healthcare technologies, today announced that it has completed an exhaustive study of a wide range of medications to treat attention-deficit hyperactivity disorder (ADHD).
Shire voluntarily recalls two lots of Daytrana product (PharmaBiz)
27 Aug 2008 at 12:43am
Noven Pharmaceuticals, Inc. provided an update on the status of Daytrana, the only transdermal patch indicated for the treatment of the symptoms of Attention Deficit Hyperactivity Disorder (ADHD).
Bachman Academy Receives Grant From Target For Art In The Environment (The Ch...
26 Aug 2008 at 7:14pm
Bachman Academy announced on Tuesday a partnership with Target in recognition of its efforts in educating children with learning disabilities such as Dyslexia, Asperger Syndrome, and Attention Deficit/Hyperactivity Disorder.
Two lots of Noven and Shire ADHD patch recalled (Reuters.co.uk)
25 Aug 2008 at 9:29am
BOSTON (Reuters) - Noven Pharmaceuticals said on Monday that its marketing partner, Shire , is voluntarily recalling two batches of its skin patch to treat attention deficit hyperactivity disorder because of difficulties removing the release liner when the patch is peeled open.